Parietaria

Known as: Parietarias, Pellitories, Pellitory 
A plant genus of the family URTICACEAE which is the most common cause of pollinosis in Mediterranean countries. It is the source of 'allergen Par o I… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1956-2017
0102019562016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Allergy to Parietaria causes significant morbidity in most Mediterranean areas. The aim of this study is to investigate the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2004
2004
BACKGROUND Allergoids are widely used in specific immunotherapy (SIT) for the treatment of IgE-mediated allergic diseases, but… (More)
Is this relevant?
2003
2003
BACKGROUND Immunotherapy is a recognized treatment for allergic respiratory diseases. OBJECTIVE To study the usefulness of… (More)
Is this relevant?
2003
2003
BACKGROUND The weed Parietaria judaica is one of the most important pollen allergen sources in the Mediterranean area… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Specific immunotherapy (SIT) is a recognized way of treating IgE-mediated respiratory diseases. The clinical outcome… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Allergic rhinitis (AR) is a high-prevalence disease in many developed countries, affecting about 10±20% of the general population… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1999
1999
BACKGROUND Sublingual-swallow immunotherapy was recently recognized in the World Health Organization Position Paper (Allergen… (More)
Is this relevant?
1999
1999
BACKGROUND The local (noninjection) routes of immunotherapy are presently regarded as viable therapeutic options for respiratory… (More)
Is this relevant?
1996
1996
Forty patients, monosensitized to Parietaria judaica with a clinical history of at least two years of rhinoconjunctivitis with or… (More)
Is this relevant?
1995
1995
A double-blind, placebo-controlled study of immunotherapy was conducted in 31 patients with allergic rhinitis due to Parietaria… (More)
Is this relevant?